{"id":"https://openalex.org/W1572509751","doi":"https://doi.org/10.3233/ppl-2009-0250","title":"Global plasma demand in 2015","display_name":"Global plasma demand in 2015","publication_year":2009,"publication_date":"2009-11-01","ids":{"openalex":"https://openalex.org/W1572509751","doi":"https://doi.org/10.3233/ppl-2009-0250","mag":"1572509751"},"language":"en","primary_location":{"id":"doi:10.3233/ppl-2009-0250","doi":"https://doi.org/10.3233/ppl-2009-0250","is_oa":true,"landing_page_url":"https://doi.org/10.3233/ppl-2009-0250","pdf_url":"https://content.iospress.com:443/download/pharmaceuticals-policy-and-law/ppl00250?id=pharmaceuticals-policy-and-law%2Fppl00250","source":{"id":"https://openalex.org/S2764382053","display_name":"Pharmaceuticals Policy and Law","issn_l":"1389-2827","issn":["1389-2827","2210-495X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals Policy and Law","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://content.iospress.com:443/download/pharmaceuticals-policy-and-law/ppl00250?id=pharmaceuticals-policy-and-law%2Fppl00250","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Patrick Robert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Patrick Robert","raw_affiliation_strings":["President, The Marketing Research Bureau, Inc., 284 Racebrook Road, Orange, CT 06477, USA. Tel.: +1 203799 0298; Fax: +1 203 891 8855"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"President, The Marketing Research Bureau, Inc., 284 Racebrook Road, Orange, CT 06477, USA. Tel.: +1 203799 0298; Fax: +1 203 891 8855","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.8813,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.92759619,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"11","issue":"4","first_page":"359","last_page":"367"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12735","display_name":"Blood donation and transfusion practices","score":0.5835000276565552,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12735","display_name":"Blood donation and transfusion practices","score":0.5835000276565552,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.24289999902248383,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.04569999873638153,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasma-fractionation","display_name":"plasma fractionation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/albumin","display_name":"albumin","score":0.7059999704360962},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.8830000162124634},{"id":"https://openalex.org/keywords/factor-viii","display_name":"factor VIII","score":0.7480000257492065},{"id":"https://openalex.org/keywords/factor-ix","display_name":"factor IX","score":0.6439999938011169},{"id":"https://openalex.org/keywords/hemophilia","display_name":"hemophilia","score":0.6959999799728394},{"id":"https://openalex.org/keywords/plasma-derived-products","display_name":"plasma-derived products","score":0.675000011920929},{"id":"https://openalex.org/keywords/market-drivers","display_name":"market drivers","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C82706917","wikidata":"https://www.wikidata.org/wiki/Q10251","display_name":"Plasma","level":2,"score":0.43180155754089355},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3325512409210205},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.11854809522628784},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.06918978691101074}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3233/ppl-2009-0250","doi":"https://doi.org/10.3233/ppl-2009-0250","is_oa":true,"landing_page_url":"https://doi.org/10.3233/ppl-2009-0250","pdf_url":"https://content.iospress.com:443/download/pharmaceuticals-policy-and-law/ppl00250?id=pharmaceuticals-policy-and-law%2Fppl00250","source":{"id":"https://openalex.org/S2764382053","display_name":"Pharmaceuticals Policy and Law","issn_l":"1389-2827","issn":["1389-2827","2210-495X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals Policy and Law","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3233/ppl-2009-0250","doi":"https://doi.org/10.3233/ppl-2009-0250","is_oa":true,"landing_page_url":"https://doi.org/10.3233/ppl-2009-0250","pdf_url":"https://content.iospress.com:443/download/pharmaceuticals-policy-and-law/ppl00250?id=pharmaceuticals-policy-and-law%2Fppl00250","source":{"id":"https://openalex.org/S2764382053","display_name":"Pharmaceuticals Policy and Law","issn_l":"1389-2827","issn":["1389-2827","2210-495X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals Policy and Law","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1572509751.pdf","grobid_xml":"https://content.openalex.org/works/W1572509751.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2086548384","https://openalex.org/W4411847470","https://openalex.org/W2536721315","https://openalex.org/W2793759098","https://openalex.org/W1827231230","https://openalex.org/W3186111265","https://openalex.org/W7216447784","https://openalex.org/W139933213","https://openalex.org/W7100847015","https://openalex.org/W2285800791"],"abstract_inverted_index":{"From":[0],"albumin":[1,47,69,228],"to":[2,65,73,171,210],"IVIG":[3],"through":[4,25,39,151],"factor":[5,167,176,217,245],"VIII:":[6],"The":[7],"three":[8,26],"phases":[9],"of":[10,56,93,101,121,137,188,235,250],"the":[11,16,20,37,40,43,49,54,60,75,112,118,132,144,152,164,186,196,206,212,223,233,241,248,259,275],"plasma":[12,21,51,57,207,236,251],"industry":[13,22],"historical":[14],"developmentOver":[15],"past":[17],"fifty":[18],"years,":[19],"has":[23],"gone":[24],"phases,":[27],"each":[28],"one":[29],"characterized":[30],"by":[31,59,240,286],"a":[32,178],"different":[33],"market":[34,76,224],"driver:":[35],"AlbuminFrom":[36],"1950's":[38],"late":[41,165],"1960's,":[42,166],"demand":[44,214,242],"for":[45,114,123,215,243,256],"human":[46,227],"determined":[48,239],"industry's":[50,197],"processing":[52],"levels:":[53],"quantity":[55],"processed":[58,237],"fractionation":[61,257],"plants":[62],"was":[63,71,107,155,238,261,272,279],"calculated":[64],"generate":[66],"just":[67],"enough":[68],"as":[70,80,199,232],"necessary":[72],"meet":[74,211],"demand.Immunoglobulins":[77],"were":[78,83,140],"considered":[79],"by-products,":[81],"and":[82,105,135,148,157,175,191,254,284,288],"available":[84,146,252,281],"in":[85,204,229,258,274,282],"large":[86],"quantities":[87],"that":[88,202],"far":[89],"exceeded":[90],"their":[91,102,149,159],"demand.Some":[92],"them":[94],"could":[95],"not":[96,128,183],"be":[97,172],"used":[98],"commercially":[99,173],"because":[100],"low":[103],"quality,":[104],"some":[106],"destroyed":[108],"after":[109],"sitting":[110],"on":[111],"shelves":[113],"several":[115],"years.Back":[116],"then,":[117],"clinical":[119,160],"potential":[120],"immunoglobulins":[122,145],"treating":[124],"immune":[125,269],"deficiencies":[126],"had":[127],"yet":[129],"been":[130],"recognized.Furthermore,":[131],"purity,":[133],"quality":[134],"safety":[136],"these":[138],"products":[139,182],"much":[141],"lower":[142],"than":[143],"today":[147],"administration":[150],"intramuscular":[153],"route":[154],"cumbersome":[156],"hampered":[158],"efficacy.":[161],"Factor":[162],"VIIIIn":[163],"VIII":[168,218],"concentrates":[169],"began":[170],"available,":[174],"IX":[177],"few":[179],"years":[180],"later.These":[181],"only":[184],"changed":[185],"lives":[187],"hemophilia":[189],"A":[190],"B":[192],"patients":[193],"but":[194],"altered":[195],"focus":[198],"well:":[200],"from":[201],"point":[203],"time,":[205],"fractionators":[208],"strived":[209],"growing":[213],"antihemophilic":[216],"concentrate.This":[219],"product":[220],"soon":[221],"became":[222],"driver,":[225],"replacing":[226],"this":[230],"role,":[231],"volume":[234,249],"plasma-derived":[244],"VIII.In":[246],"1992,":[247],"(recovered":[253],"source)":[255],"US":[260],"about":[262],"8":[263],"million":[264],"liters.In":[265],"1982,":[266],"polyvalent":[267],"intravenous":[268],"globulin":[270],"(IVIG)":[271],"launched":[273],"United":[276],"States":[277],"(it":[278],"already":[280],"Germany":[283],"Japan)":[285],"Sandoz":[287],"Cutter.":[289]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}